$SLXN
Silexion Therapeutics Corp Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.163
▼-6.70%-$0.012
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSilexion Therapeutics Corp Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SLXN down today? It is at $0.163 (-6.70%), and our scanner flagged it 104 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SLXN spikes, and full due diligence on SLXN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SLXN 104 times in the last 30 days. Create a free account to track $SLXN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SLXN from our scanner (live price and day move above). Fresh from the SEC: Silexion Therapeutics Corp filed an 8-K: Charter / Bylaw Change, Shareholder Vote. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystCharter / Bylaw Change · Shareholder VoteReverse split 1-for-24Status pending stockholder approval, from the latest SEC filing. Read it →Across every filing on file, supply equal to 575.4% of the tradeable float is in play - 14.1% has already been sold, and 561.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Recent share offering + active shelf on file — the company raised capital and can raise more
2,028,619 new shares · About $840K in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hadar Ilan Officer | Acquired (grant/award) | +10K 0.07% of company | added 100% | 17K | n/a | Jun 4, 26 |
Horenshtein Hadar Mirit Officer | Acquired (grant/award) | +8K 0.05% of company | added 100% | 13K | n/a | Jun 4, 26 |
Shirvan Mitchell Officer | Acquired (grant/award) | +6K 0.04% of company | added 100% | 9K | n/a | Jun 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SLXN from our scanner (live price and day move above). Fresh from the SEC: Silexion Therapeutics Corp filed an 8-K: Charter / Bylaw Change, Shareholder Vote. A material company disclosure like this is often the real catalyst behind a move of this size.
SLXN last traded at $0.163, down 6.70% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Silexion Therapeutics Corp Ordinary Shares (SLXN) is next expected to report earnings on Wednesday, November 11, 2026, about 14 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SLXN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SLXN 104 times in the last 30 days.
SLXN (Silexion Therapeutics Corp Ordinary Shares) trades on XNAS, with a market cap of about $2M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SLXN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SLXN discussion
Sign in to ask a question or join the discussion.